THG is trading at £30.52, up +10.90%, after raising its 2026 adjusted EBITDA expectation to £103m, ahead of market consensus, following stronger-than-expected Q3 profitability.
- Q3 group revenue was £408.8m, up 1.5% year-on-year on a constant-currency basis; Myprotein unit volumes rose 36.2%.
- Nutrition performance and lower whey-protein costs supported the upgrade; whey concentrate prices had fallen around 20% since September.